VCYT 8-K 2026-11-04

VERACYTE, INC. (VCYT) 8-K dated 2026-11-04 — accession 0001384101-26-000053.

VERACYTE, INC. (VCYT) is a diagnostics & research company listed on NASDAQ.

VERACYTE, INC. filed a 8-K on 2026-11-04. Accession 0001384101-26-000053.

This 8-K covers: Results of operations (Item 2.02), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VCYT revenue for 2025-12-31 was $517.1M. Net income was $66.4M. Revenue was up 16.0% from 2024-12-31 to 2025-12-31. VCYT currently screens at market cap $4.09B and trailing P/E 17.1.

Not investment advice. The VCYT SEC hub lists recent forms. The stock page is the research view.